Iwasaku, M., Uchino, J., Yamada, T., Chihara, Y., Shimamoto, T., Tamiya, N., . . . Takayama, K. (2019). Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study). Transl Lung Cancer Res.

Iwasaku, Masahiro, Junji Uchino, Tadaaki Yamada, Yusuke Chihara, Takayuki Shimamoto, Nobuyo Tamiya, Yoshiko Kaneko, Fumiaki Kiyomi, và Koichi Takayama. "Rationale and Design of a Phase II Study to Evaluate Prophylactic Treatment of Dacomitinib-induced Dermatologic Adverse Events in Epidermal Growth Factor Receptor-mutated Advanced Non-small Cell Lung Cancer (SPIRAL-Daco Study)." Transl Lung Cancer Res 2019.

Iwasaku, Masahiro, et al. "Rationale and Design of a Phase II Study to Evaluate Prophylactic Treatment of Dacomitinib-induced Dermatologic Adverse Events in Epidermal Growth Factor Receptor-mutated Advanced Non-small Cell Lung Cancer (SPIRAL-Daco Study)." Transl Lung Cancer Res 2019.